Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Sabatine

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Circulation|December 6, 2001
Will diabetes save the platelet blockers?M S Sabatine, E Braunwald
The American Journal of Medicine|September 7, 2000
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery diseaseM S Sabatine, I K Jang
Minerva Cardioangiologica|October 11, 2003
The management of unstable angina and non-ST-segment elevation myocardial infartionA A Chen, M S Sabatine
Acta Cardiologica|April 24, 1999
Antithrombotic therapy in acute coronary syndromesM S Sabatine, I K Jang
Journal of Thrombosis and Thrombolysis|September 27, 2000
Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplaseM S Sabatine, T M Tu, I K Jang
Acta Cardiologica|July 21, 2000
Primary versus rescue percutaneous coronary intervention in patients with acute myocardial infarctionG Gimelli, A Kalra, M S Sabatine, et al.
Chest|December 24, 1997
Pulmonary cholesterol crystal embolizationM S Sabatine, D A Oelberg, E J Mark, et al.
Journal of Thrombosis and Thrombolysis|September 29, 2001
Elevation in serum troponin I predicts the benefit of tirofibanJ L Januzzi, C U Chae, M S Sabatine, et al.
The American Journal of Cardiology|August 29, 2001
A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectorisM S Sabatine, J L Januzzi, S Snapinn, et al.
Transplantation|February 3, 1998
Delayed rejection of soluble tumor necrosis factor receptor-secreting tumor allograftsM S Sabatine, T Laufer, L H Glimcher, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Circulation|December 6, 2001
Will diabetes save the platelet blockers?M S Sabatine, E Braunwald
The American Journal of Medicine|September 7, 2000
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery diseaseM S Sabatine, I K Jang
Minerva Cardioangiologica|October 11, 2003
The management of unstable angina and non-ST-segment elevation myocardial infartionA A Chen, M S Sabatine
Acta Cardiologica|April 24, 1999
Antithrombotic therapy in acute coronary syndromesM S Sabatine, I K Jang
Journal of Thrombosis and Thrombolysis|September 27, 2000
Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplaseM S Sabatine, T M Tu, I K Jang
Acta Cardiologica|July 21, 2000
Primary versus rescue percutaneous coronary intervention in patients with acute myocardial infarctionG Gimelli, A Kalra, M S Sabatine, et al.
Chest|December 24, 1997
Pulmonary cholesterol crystal embolizationM S Sabatine, D A Oelberg, E J Mark, et al.
Journal of Thrombosis and Thrombolysis|September 29, 2001
Elevation in serum troponin I predicts the benefit of tirofibanJ L Januzzi, C U Chae, M S Sabatine, et al.
The American Journal of Cardiology|August 29, 2001
A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectorisM S Sabatine, J L Januzzi, S Snapinn, et al.
Transplantation|February 3, 1998
Delayed rejection of soluble tumor necrosis factor receptor-secreting tumor allograftsM S Sabatine, T Laufer, L H Glimcher, et al.
Pageof 2